CVS to Cover Lilly’s GLP-1 Medications, Expanding Access
CVS Health will broaden coverage for Lilly’s GLP-1 medications, including the new pill Foundayo and Zepbound injectio...
Timing can make a difference in redeeming credit card rewards. Discover the best moments to redeem for maximum value.
23,143 articlesCVS Health will broaden coverage for Lilly’s GLP-1 medications, including the new pill Foundayo and Zepbound injectio...
A mobility startup defies the VC playbook, raising $15 million from private investors. The story highlights disciplin...
CoStar Group has agreed to acquire Bora Inc., the parent of Zonda, from MidOcean Partners for $800 million in cash, a...
Eli Lilly has been a standout growth stock thanks to GLP-1 drug demand. Could a stock split be on the horizon? This g...
XLRE has surged about 11% year-to-date, but analysts warn that rising yields could pressure capital gains while AFFO-...
Institutional buyers added to Solana spot ETFs in May, delivering zero net outflows for the month and fueling specula...
A software stock that doubled since April caught my eye for reasons beyond hype. In this guide, I explain the growth ...
Broadcom's June earnings could upend market expectations. This deep-dive explains why the report may matter more than...
As AI compute ramps up, memory has become a bottleneck. Intel’s 2021 $9 billion NAND sale to SK Hynix is drawing rene...
Rambus navigates a cooling memory-chip cycle that could weigh on margins even as AI infrastructure demand remains a k...
As investors assess concentrix (cnxc) 2026 earnings, this guide breaks down what to watch, how margins may move, and ...
Cardano teams with Brazil's Olympic Committee to modernize sports administration using AI, blockchain, and IoT. ADA r...